Introduction
Therapeutic ultrasound (US) is a common form of treatment the repair of damaged tissues.
This non-invasive application of acoustic energy at low megahertz frequencies (up to 3000 mW / cm 2 ) has been utilized to treat over one million patients each year in the UK, constituting 20% of all treatments within hospital physiotherapy departments [1] Beneficial responses to the application of US have been demonstrated in several soft tissue animal models, with improved healing rates [2] and tissue strength [3] . Moreover, clinical trials have also reported beneficial results at soft tissue wound sites such as venous ulcers [4] and the elbow joint [5] . In addition, US treatment of hard tissue injuries, such as bone fractures, have proved highly successful with markedly improved healing rates of human fractures (approximately 30-40%) [6, 7] .
Animal studies have also provided evidence of enhanced fracture healing, particularly at the lower range of clinical intensity values [8, 9] .
The potential for applying Therapeutic US to improve the clinical efficiency of implant materials has been demonstrated with improved rates of bone regeneration and bioabsorption of UStreated DP-Bioglass implants [10] and also improved rates and extent of bone ingrowth using UStreated porous-coated impants [11] .
The studies noted above and widespread clinical experience strongly suggest that there is a clear potential of the use of US as a non-invasive method to enhance tissue repair and regeneration processes. However, the mechanisms involved in initiating favourable cellular responses from ultrasonic stimulation are poorly understood, and little is known about the optimum acoustical conditions which elicit such beneficial responses. The aim of this study was therefore to determine the relationship between intensity levels of applied US and activity of two bone-associated genes, alkaline phosphatase (ALP) and osteopontin (OP), which play fundamental roles in the growth and function of bone.
Materials and methods
The osteoblast-like cell line MG63 was seeded onto 10 cm 2 slide chamber flasks (Nunc; Naperville; IL; USA) and grown to confluence in medium consisting of Dulbecco's Minimum Essential Medium (DMEM) (Gibco Life Technologies Ltd; Paisley, UK), 10% heat-inactivated fetal calf serum (FCS) (PAA Laboratories; Linz, Austria), 2 mM L-glutamine (Gibco), 100 U/ml of penicillin (Gibco) and 100 mg/ml of streptomycin (Gibco) at 37°C in a humidified atmosphere of 5% CO 2 in air. The flasks were filled with medium and then exposed 3.0 MHz ultrasound for 10 min, at intensity levels of 120, 390 and 1490 mW / cm 2 . Control cultures received no exposure to US.
Exposure was performed in a water bath exposure assembly, as shown in Cells were harvested by trypsinisation and subsequent centrifugation. RNA was isolated from cells within the slide chamber target region by the single step method of Chomcynski and Sacchi [12] .
Briefly, it was important to achieve this rapidly and efficiently to inhibit the endogenous ribonucleases, which are present in virtually all living cells. High-quality RNA greatly increases the efficiency of RT-PCR. The isolated RNA was then reverse transcribed into first strand complimentary DNA (cDNA), and then amplified using oligonucleotide primers specific for the bone-associated proteins ALP and OP, using a previously published protocol [13] . each US intensity, relative to non-exposed control, was calculated.
Thus, although the GAPDH remained at the same band intensity for all doses of ultrasound (and the same as the control cultures which recorded no ultrasound exposure), the expression of the both the ALP and OP genes were found to vary at different US intensities. As seen in Fig. 3 ., ALP expression relative to GAPDH expression was found to be 10% above control levels for 120 mW / cm 2 , in excess of double at 390 mW / cm 2 and more than four times greater at 1490 mW / cm 2 . However, OP expression (Fig. 4. ) was down-regulated by 40% at the lowest dose of 120 mW / cm 2 , while upregulation by 30% and 60% was measured at 390 mW / cm 2 and 1490 mW / cm 2 respectively. .
Discussion and conclusion
Exposure to therapeutic doses of US was found to alter the expression of the bone-associated genes ALP and OP at 6 h post-insonation in osteoblast-like cells. At the highest two doses, ALP and OP expression were both clearly up-regulated, particularly for ALP. However at the lowest dose, a differential response was found with down-regulation of OP to little variation from control for ALP.
altered expression of these genes due to ultrasound stimulation, such as up-regulation of ALP and OP at higher doses. However, the down-regulation of OP at the lowest intensity exposure may infer that the response of cells to ultrasound may be highly dose-specific. Such an observation is consistent with findings of optimal fracture healing in vivo at the lower end of the therapeutic US intensity range.
These results suggest the possibility that ultrasound exposure parameters could be modulated to optimise the clinical efficacy of ultrasound for engineering new bone and improving implant biocompatability. 
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